Dr. Reddy's Laboratories Ltd. today announced the appointment of Erez Israeli, former President and CEO of Enzymotec, as the Chief Operating Officer (COO), succeeding Abhijit Mukherjee, who will retire on March 31 after a 15-year career with the company.
Israeli will join Dr. Reddy's on April two as Chief Operating Officer and Global Head of Generics & PSAI, based out of Hyderabad.
He will report to Dr. Reddy's Co-Chairman & CEO, G V Prasad, a company statement said.
In a career spanning over 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, the statement said.
Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including Vice-President-Marketing & Sales for North America, Vice-President Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO Growth Markets, it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
